Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baxdrostat in Chinese Participants With Uncontrolled Hypertension
NCT07686120Phase 3Recruiting
- Sponsor
- AstraZeneca
- Start
- Sep 2026
- Primary completion
- Feb 2028
- Countries
- 1
01
Overview
A Phase 3 trial of baxdrostat in hypertension (HTN), sponsored by AstraZeneca. Started Sep 2026; status: recruiting.
02
Drugs
baxdrostat
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07686120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07686120.